- Report
- October 2024
- 188 Pages
Global
From €3238EUR$3,545USD£2,769GBP
€3598EUR$3,939USD£3,076GBP
- Report
- April 2025
- 194 Pages
Global
From €5343EUR$5,850USD£4,569GBP
- Report
- February 2025
- 200 Pages
Global
From €4101EUR$4,490USD£3,507GBP
- Report
- July 2024
- 185 Pages
Global
From €4110EUR$4,500USD£3,515GBP
- Report
- September 2024
- 115 Pages
Global
From €4110EUR$4,500USD£3,515GBP
- Report
- November 2024
- 1159 Pages
Global
€1816EUR$2,057USD£1,500GBP
- Report
- May 2024
- 1175 Pages
Global
€1816EUR$2,057USD£1,500GBP
- Report
- December 2024
- 180 Pages
Global
From €4247EUR$4,650USD£3,632GBP
- Report
- March 2025
- 185 Pages
Global
From €3238EUR$3,545USD£2,769GBP
€3598EUR$3,939USD£3,076GBP
- Report
- October 2024
- 192 Pages
Global
From €3238EUR$3,545USD£2,769GBP
€3598EUR$3,939USD£3,076GBP
- Report
- March 2025
- 185 Pages
Global
From €3238EUR$3,545USD£2,769GBP
€3598EUR$3,939USD£3,076GBP
- Report
- October 2024
- 188 Pages
Global
From €3238EUR$3,545USD£2,769GBP
€3598EUR$3,939USD£3,076GBP
- Report
- October 2024
- 120 Pages
Global
From €5434EUR$5,950USD£4,647GBP
- Report
- February 2025
- 110 Pages
Global
From €5434EUR$5,950USD£4,647GBP
- Report
- December 2024
- 100 Pages
Global
From €5434EUR$5,950USD£4,647GBP
- Report
- September 2024
- 141 Pages
Global
From €2739EUR$2,999USD£2,342GBP
- Report
- February 2025
- 200 Pages
Global
From €4101EUR$4,490USD£3,507GBP
- Report
- February 2025
- 200 Pages
Global
From €4101EUR$4,490USD£3,507GBP
- Report
- April 2025
- 175 Pages
Global
From €4101EUR$4,490USD£3,507GBP
- Report
- April 2025
- 200 Pages
Global
From €4101EUR$4,490USD£3,507GBP

Downstream Processing (DSP) is a biotechnology process used to purify and concentrate biopharmaceuticals, such as proteins, antibodies, and enzymes. It is a critical step in the production of biopharmaceuticals, as it ensures the quality and safety of the final product. DSP involves a series of steps, such as filtration, chromatography, and ultrafiltration, to separate and purify the desired product from the rest of the components. The process is highly complex and requires specialized equipment and expertise.
The DSP market is growing rapidly, driven by the increasing demand for biopharmaceuticals and the need for efficient and cost-effective production processes. The market is expected to continue to grow in the coming years, driven by technological advancements and the increasing demand for biopharmaceuticals.
Some of the major companies in the DSP market include Merck KGaA, GE Healthcare, Thermo Fisher Scientific, Sartorius AG, and Pall Corporation. Show Less Read more